Clinical Trial Update: Phase II Tularemia Vaccine Comparison [Phase 2]

View source ↗

Summary

A Phase II trial comparing tularemia vaccines conducted by NIAID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tularemia

Drugs mentioned

• Tularemia vaccine (Phase II comparator)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tularaemia | Phase 2 | Status: COMPLETED